Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2025
13,000 people to benefit from new insulin medicine
11 April 2025 - Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from ...
Posted by Michael Wonder on 10 Apr 2025
PHARMAC to fund medicines for blood cancers, inflammatory bowel disease, eczema and arthritis
10 April 2025 - More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, ...
Posted by Michael Wonder on 07 Apr 2025
Rule of Two for faster access to medicines
3 April 2025 - Associate Health Minister David Seymour is welcoming Cabinet’s decision to enable medicines to be approved in ...
Posted by Michael Wonder on 31 Mar 2025
PHARMAC proposing to fund two brands of oestradiol patches
27 March 2025 - PHARMAC is seeking feedback on a proposal to fund two brands of oestradiol patches for New ...
Posted by Michael Wonder on 12 Mar 2025
PHARMAC to fund more cancer medicines (March 2025)
12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
New insulin medicine proposed for people with diabetes
10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...
Posted by Michael Wonder on 03 Mar 2025
PHARMAC CE resigns
28 February 2025 - The Board of PHARMAC wishes to announce that its Chief Executive for the last 7 years, ...
Posted by Michael Wonder on 03 Mar 2025
New Zealand Pharmaceutical Schedule - 1 March 2025
1 March 2025 - The March 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 12 Feb 2025
PHARMAC funds medicines for liver, ovarian, and neuroendocrine cancers
12 February 2025 - People with liver, ovarian, and neuroendocrine cancers will have access to more medicines from 1 March ...
Posted by Michael Wonder on 03 Feb 2025
Proposal to fund a new oral contraceptive pill
3 February 2025 - PHARMAC is consulting on funding a new progestogen-only oral contraceptive pill called desogestrel (Cerazette) from 1 ...
Posted by Michael Wonder on 01 Feb 2025
New Zealand Pharmaceutical Schedule - 1 February 2025
1 February 2025 - The February 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Feb 2025
PHARMAC reconsiders oestradiol patch options following community feedback
29 January 2025 - PHARMAC is reviewing and reconsidering its oestradiol patch options after considerable feedback was received when it ...
Posted by Michael Wonder on 16 Jan 2025
PHARMAC consulting on widening access to venetoclax, azacitidine and upadacitinib monohydrate
16 January 2025 - PHARMAC is asking for feedback on a proposal to widen access to three medicines for five ...
Posted by Michael Wonder on 12 Jan 2025
2,000 people to benefit from medicine for osteoporosis and people with high blood calcium and cancer
10 January 2025 - PHARMAC is widening access to a medicine called denosumab for people with osteoporosis. ...